Abstract: Compounds of formula (2) or pharmaceutically acceptable salts thereof are provided: wherein each of R1a, R2a, R3a, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia.
Compounds of formula (2) or pharmaceutically acceptable salts thereof are provided: wherein each of R1a, R2a, R3a, Ar, y, and m are as defined herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, are used to treat a variety of central nervous system disorders such as schizophrenia.
| # | Name | Date |
|---|---|---|
| 1 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-1.pdf | 2018-09-10 |
| 1 | abstract-03951-kolnp-2007.jpg | 2011-10-08 |
| 2 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-2.pdf | 2018-09-10 |
| 2 | 3951-KOLNP-2007-PCT PRIORITY DOCUMENT NOTIFICATION.pdf | 2011-10-08 |
| 3 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-3.pdf | 2018-09-10 |
| 3 | 3951-kolnp-2007-form-18.pdf | 2011-10-08 |
| 4 | ABANDONED LETTER.pdf | 2016-12-02 |
| 4 | 3951-KOLNP-2007-FORM 3-1.1.pdf | 2011-10-08 |
| 5 | FIRST EXAMINATION LETTER.pdf | 2016-12-02 |
| 5 | 3951-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf | 2011-10-08 |
| 6 | 3951-KOLNP-2007-ABANDONED LETTER.pdf | 2016-10-06 |
| 6 | 03951-kolnp-2007-international search report.pdf | 2011-10-08 |
| 7 | 3951-KOLNP-2007-FIRST EXAMINATION REPORT.pdf | 2016-10-06 |
| 7 | 03951-kolnp-2007-gpa.pdf | 2011-10-08 |
| 8 | 3951-KOLNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 8 | 03951-kolnp-2007-form 5.pdf | 2011-10-08 |
| 9 | 03951-kolnp-2007-abstract.pdf | 2011-10-08 |
| 9 | 03951-kolnp-2007-form 3.pdf | 2011-10-08 |
| 10 | 03951-kolnp-2007-claims.pdf | 2011-10-08 |
| 10 | 03951-kolnp-2007-form 1.pdf | 2011-10-08 |
| 11 | 03951-kolnp-2007-correspondence others.pdf | 2011-10-08 |
| 12 | 03951-kolnp-2007-claims.pdf | 2011-10-08 |
| 12 | 03951-kolnp-2007-form 1.pdf | 2011-10-08 |
| 13 | 03951-kolnp-2007-abstract.pdf | 2011-10-08 |
| 13 | 03951-kolnp-2007-form 3.pdf | 2011-10-08 |
| 14 | 03951-kolnp-2007-form 5.pdf | 2011-10-08 |
| 14 | 3951-KOLNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 15 | 03951-kolnp-2007-gpa.pdf | 2011-10-08 |
| 15 | 3951-KOLNP-2007-FIRST EXAMINATION REPORT.pdf | 2016-10-06 |
| 16 | 03951-kolnp-2007-international search report.pdf | 2011-10-08 |
| 16 | 3951-KOLNP-2007-ABANDONED LETTER.pdf | 2016-10-06 |
| 17 | 3951-KOLNP-2007-CORRESPONDENCE OTHERS 1.1.pdf | 2011-10-08 |
| 17 | FIRST EXAMINATION LETTER.pdf | 2016-12-02 |
| 18 | 3951-KOLNP-2007-FORM 3-1.1.pdf | 2011-10-08 |
| 18 | ABANDONED LETTER.pdf | 2016-12-02 |
| 19 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-3.pdf | 2018-09-10 |
| 19 | 3951-kolnp-2007-form-18.pdf | 2011-10-08 |
| 20 | 3951-KOLNP-2007-PCT PRIORITY DOCUMENT NOTIFICATION.pdf | 2011-10-08 |
| 20 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-2.pdf | 2018-09-10 |
| 21 | abstract-03951-kolnp-2007.jpg | 2011-10-08 |
| 21 | 3951-KOLNP-2007-INTERNATIONAL PUBLICATION-1.pdf | 2018-09-10 |